Cargando…

Prevention of delirium with agitation by yokukansan in older adults after cancer surgery

OBJECTIVE: Preventing postoperative delirium with agitation is vital in the older population. We examined the preventive effect of yokukansan on postoperative delirium with agitation in older adult patients undergoing highly invasive cancer resection. METHODS: We performed a secondary per-protocol a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sadahiro, Ryoichi, Wada, Saho, Matsuoka, Yutaka J, Uchitomi, Yosuke, Yamaguchi, Takuhiro, Sato, Tetsufumi, Esaki, Minoru, Yoshimoto, Seiichi, Daiko, Hiroyuki, Kanemitsu, Yukihide, Kawai, Akira, Kato, Tomoyasu, Fujimoto, Hiroyuki, Uezono, Yasuhito, Shimizu, Ken, Matsuoka, Hiromichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631458/ https://www.ncbi.nlm.nih.gov/pubmed/35907781 http://dx.doi.org/10.1093/jjco/hyac123

Ejemplares similares

Yokukansan for perioperative psychiatric symptoms in cancer patients undergoing high invasive surgery. J-SUPPORT 1605 (ProD Study): study protocol for a randomized controlled trial
por: Wada, Saho, et al.
Publicado: (2019)

Data-driven categorization of postoperative delirium symptoms using unsupervised machine learning
por: Sri-iesaranusorn, Panyawut, et al.
Publicado: (2023)

Pilot Study of Lemborexant for Insomnia in Cancer Patients with Delirium
por: Terada, Tatsuto, et al.
Publicado: (2022)

A multi-centre, double-blind, randomized, placebo-controlled trial to evaluate the effectiveness and safety of ramelteon for the prevention of postoperative delirium in elderly cancer patients: a study protocol for JORTC-PON2/J-SUPPORT2103/NCCH2103
por: Sadahiro, Ryoichi, et al.
Publicado: (2023)

Ketamine Improves Desensitization of µ-Opioid Receptors Induced by Repeated Treatment with Fentanyl but Not with Morphine
por: Mizobuchi, Yusuke, et al.
Publicado: (2022)

Tackling agitated delirium – the tip of the iceberg
por: Page, Valerie J
Publicado: (2009)

Randomized phase II study of TJ-54 (Yokukansan) for postoperative delirium in gastrointestinal and lung malignancy patients
por: Sugano, Nobuhiro, et al.
Publicado: (2017)

Emergence agitation/delirium: we still don't know
por: Kwak, Kyung Hwa
Publicado: (2010)

The Effect of the Kampo Medicine Yokukansan on Preoperative Anxiety and Sedation Levels
por: Arai, Young-Chang, et al.
Publicado: (2014)

Yokukansan, a Traditional Japanese Medicine, Adjusts Glutamate Signaling in Cultured Keratinocytes
por: Wakabayashi, Maki, et al.
Publicado: (2014)

Clinical review: Agitation and delirium in the critically ill – significance and management
por: Chevrolet, Jean-Claude, et al.
Publicado: (2007)

Prevention and treatment of sevoflurane emergence agitation and delirium in children with dexmedetomidine
por: Ayeko, Michael, et al.
Publicado: (2014)

Prevention and treatment of sevoflurane emergence agitation and delirium in children with dexmedetomidine
por: Ayeko, Michael, et al.
Publicado: (2015)

Applying (or Not?) CAR-T Neurotoxicity Experience to COVID-19 Delirium and Agitation
por: Mack, Avram H., et al.
Publicado: (2020)

Yokukansan enhances the proliferation of B65 neuroblastoma
por: Nakatani, Yoshihiko, et al.
Publicado: (2016)

Multiple drugs: Delirium, worsening of agitation and confusion and ineffectiveness: case report
Publicado: (2020)

Emergence Agitation and Delirium: Considerations for Epidemiology and Routine Monitoring in Pediatric Patients
por: Menser, Carrie, et al.
Publicado: (2020)

Yokukansan and its ingredients as possible treatment options for schizophrenia
por: Yu, Chuan-Hsun, et al.
Publicado: (2014)

Potential Application of Yokukansan as a Remedy for Parkinson's Disease
por: Jang, Jung-Hee, et al.
Publicado: (2018)

Randomised Double-blind Placebo-Controlled Multicentre Trial for the Effects of Yokukansan in Smokers with Depressive Tendencies
por: Komiyama, Maki, et al.
Publicado: (2023)

Changes in practice for mechanically ventilated patients: effect of the pain, agitation, and delirium guidelines
por: Huh, Jin Won
Publicado: (2022)

Effects of Rhizobium Species Living with the Dark Septate Endophytic Fungus Veronaeopsis simplex on Organic Substrate Utilization by the Host
por: Guo, Yong, et al.
Publicado: (2018)

Amantadine: Hallucinations, agitation and withdrawal syndrome in the form of prolonged hypoactive delirium: case report
Publicado: (2021)

The clinical use of Kampo medicines (traditional Japanese herbal treatments) for controlling cancer patients’ symptoms in Japan: a national cross-sectional survey
por: Iwase, Satoru, et al.
Publicado: (2012)

Ameliorating effect of Yokukansan on the development of atopic dermatitis-like lesions and scratching behavior in socially isolated NC/Nga mice
por: Funakushi, Naoko, et al.
Publicado: (2011)

Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function
por: Takeyoshi, Kenji, et al.
Publicado: (2016)

Antistress effects of Kampo medicine “Yokukansan” via regulation of orexin secretion
por: Katahira, Haruto, et al.
Publicado: (2017)

Kampo Formulae for the Treatment of Neuropathic Pain ∼ Especially the Mechanism of Action of Yokukansan ∼
por: Sunagawa, Masataka, et al.
Publicado: (2021)

A Case of Pseudohyperaldosteronism Induced by Yokukansan and Shakuyakukanzoto That Resulted in Severe Hypokalemia
por: Arai, Mika, et al.
Publicado: (2023)

J‐SUPPORT research policy for oral mucositis associated with cancer treatment
por: Yokota, Tomoya, et al.
Publicado: (2022)

Comparison of clinical practice guidelines for the management of pain, agitation, and delirium in critically ill adult patients
por: Tsuruta, Ryosuke, et al.
Publicado: (2018)

A National Multicenter Survey on Management of Pain, Agitation, and Delirium in Intensive Care Units in China
por: Wang, Jing, et al.
Publicado: (2017)

Ketamine Safety and Use in the Emergency Department for Pain and Agitation/Delirium: A Health System Experience
por: Mo, Hanjie, et al.
Publicado: (2020)

Pet-Assisted Therapy for Delirium and Agitation in Hospitalized Patients with Neurocognitive Impairment: A Review of Literature
por: Sheikh, Abu Baker, et al.
Publicado: (2021)

Pharmacological Management of Agitation and Delirium in Older Adults: a Survey of Practices in Canadian Emergency Departments
por: Russek, Natanya S., et al.
Publicado: (2023)

Yokukansan promotes hippocampal neurogenesis associated with the suppression of activated microglia in Gunn rat
por: Furuya, Motohide, et al.
Publicado: (2013)

Cellular Pharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan on Brain Cells
por: Mizoguchi, Kazushige, et al.
Publicado: (2017)

Medication Overuse Headache Successfully Treated by Japanese Herbal Kampo Medicine, Yokukansan
por: Katsuki, Masahito, et al.
Publicado: (2021)

Yokukansan Suppresses Gastric Hypersensitivity and Eosinophil-associated Microinflammation in Rats With Functional Dyspepsia
por: Duan, Shaoqi, et al.
Publicado: (2022)

Yokukansan Inhibits the Development of Morphine Tolerance by Regulating Presynaptic Proteins in DRG Neurons
por: Ohashi, Yusuke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3vb0si60e3vnpsoh3eu08ls9mi